BODAL CHEMICALS LIMITED Financials Bodal Chemicals Limited NSE India S.E.
Equities
BODALCHEM
INE338D01028
Specialty Chemicals
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 77.8 INR | -1.46% |
|
-1.21% | -5.93% |
| Mar. 06 | Bodal Chemicals Limited announced that it expects to receive INR 214 million in funding | CI |
| Feb. 13 | Transcript : Bodal Chemicals Limited, Q3 2024 Earnings Call, Feb 13, 2024 |
Valuation
| Fiscal Period: March | 2019 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 15,487 | 11,016 | 12,346 | 7,253 | 9,794 | - | - |
| Enterprise Value (EV) 1 | 15,487 | 11,016 | 12,346 | 7,253 | 9,794 | 9,794 | 9,794 |
| P/E ratio | 11 x | - | - | 19.1 x | 130 x | 21 x | 13.5 x |
| Yield | - | 0.89% | 0.79% | - | 1.28% | 1.28% | 1.28% |
| Capitalization / Revenue | 1.08 x | 0.9 x | 0.6 x | 0.46 x | 0.7 x | 0.56 x | 0.5 x |
| EV / Revenue | 1.08 x | 0.9 x | 0.6 x | 0.46 x | 0.7 x | 0.56 x | 0.5 x |
| EV / EBITDA | 6.21 x | 13 x | 5.21 x | 5.44 x | 9.69 x | 5.91 x | 4.94 x |
| EV / FCF | - | -5.76 x | -7.15 x | - | -7.94 x | -9.47 x | 52.4 x |
| FCF Yield | - | -17.4% | -14% | - | -12.6% | -10.6% | 1.91% |
| Price to Book | - | 1.13 x | 1.17 x | - | 0.91 x | 0.88 x | 0.83 x |
| Nbr of stocks (in thousands) | 122,189 | 122,330 | 122,482 | 125,623 | 125,790 | - | - |
| Reference price 2 | 126.8 | 90.05 | 100.8 | 57.74 | 77.86 | 77.86 | 77.86 |
| Announcement Date | 5/21/19 | 6/24/21 | 5/27/22 | 5/30/23 | - | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2019 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 14,369 | 12,264 | 20,506 | 15,743 | 13,948 | 17,390 | 19,403 |
| EBITDA 1 | 2,495 | 845.8 | 2,369 | 1,333 | 1,011 | 1,656 | 1,982 |
| EBIT 1 | - | 541 | 1,903 | - | 601 | 1,162 | 1,658 |
| Operating Margin | - | 4.41% | 9.28% | - | 4.31% | 6.68% | 8.55% |
| Earnings before Tax (EBT) 1 | 2,192 | 553.8 | 1,420 | 508.4 | 103.5 | 619.5 | 962 |
| Net income 1 | 1,413 | 419.8 | 1,077 | 380.3 | 76.5 | 464 | 721 |
| Net margin | 9.83% | 3.42% | 5.25% | 2.42% | 0.55% | 2.67% | 3.72% |
| EPS 2 | 11.54 | - | - | 3.030 | 0.6000 | 3.700 | 5.750 |
| Free Cash Flow 1 | - | -1,911 | -1,726 | - | -1,234 | -1,034 | 187 |
| FCF margin | - | -15.59% | -8.42% | - | -8.85% | -5.95% | 0.96% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | 9.43% |
| FCF Conversion (Net income) | - | - | - | - | - | - | 25.94% |
| Dividend per Share 2 | - | 0.8000 | 0.8000 | - | 1.000 | 1.000 | 1.000 |
| Announcement Date | 5/21/19 | 6/24/21 | 5/27/22 | 5/30/23 | - | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: Marzo | 2022 Q1 | 2022 Q3 | 2022 Q4 | 2024 Q3 |
|---|---|---|---|---|
| Net sales 1 | - | 5,618 | 5,973 | 3,550 |
| EBITDA 1 | - | 683.3 | 538 | 266 |
| EBIT | - | - | - | - |
| Operating Margin | - | - | - | - |
| Earnings before Tax (EBT) | 381.2 | - | - | - |
| Net income 1 | 298.6 | 200.5 | - | 27 |
| Net margin | - | 3.57% | - | 0.76% |
| EPS | - | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 8/14/21 | 2/11/22 | 5/27/22 | - |
1INR in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: Marzo | 2019 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | -1,911 | -1,726 | - | -1,234 | -1,034 | 187 |
| ROE (net income / shareholders' equity) | 18.5% | 4.4% | 10.6% | 3.57% | 0.7% | 4.2% | 6.2% |
| ROA (Net income/ Total Assets) | 11.9% | - | - | 1.79% | 0.3% | 1.9% | 2.4% |
| Assets 1 | 11,868 | - | - | 21,247 | 25,500 | 24,421 | 30,042 |
| Book Value Per Share 2 | - | 79.70 | 86.20 | - | 85.20 | 88.20 | 94.10 |
| Cash Flow per Share | - | - | - | - | - | - | - |
| Capex 1 | 1,482 | 1,781 | 1,591 | 3,378 | 2,722 | 842 | 243 |
| Capex / Sales | 10.32% | 14.52% | 7.76% | 21.45% | 19.51% | 4.84% | 1.25% |
| Announcement Date | 5/21/19 | 6/24/21 | 5/27/22 | 5/30/23 | - | - | - |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
77.86
INR
Average target price
90
INR
Spread / Average Target
+15.59%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +14.02% | 64.66B | |
| -3.80% | 46.08B | |
| +13.26% | 39.72B | |
| +19.28% | 25.82B | |
| +8.22% | 18.8B | |
| -1.13% | 17.14B | |
| -21.03% | 15.86B | |
| +1.06% | 15.05B | |
| -16.73% | 14.14B |
- Stock Market
- Equities
- BODALCHEM Stock
- BODALCHEM Stock
- Financials Bodal Chemicals Limited
